全文获取类型
收费全文 | 3398篇 |
免费 | 387篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 89篇 |
妇产科学 | 66篇 |
基础医学 | 433篇 |
口腔科学 | 66篇 |
临床医学 | 438篇 |
内科学 | 590篇 |
皮肤病学 | 67篇 |
神经病学 | 388篇 |
特种医学 | 113篇 |
外科学 | 461篇 |
综合类 | 104篇 |
一般理论 | 1篇 |
预防医学 | 358篇 |
眼科学 | 95篇 |
药学 | 278篇 |
中国医学 | 1篇 |
肿瘤学 | 211篇 |
出版年
2022年 | 27篇 |
2021年 | 46篇 |
2020年 | 36篇 |
2019年 | 54篇 |
2018年 | 63篇 |
2017年 | 41篇 |
2016年 | 46篇 |
2015年 | 61篇 |
2014年 | 78篇 |
2013年 | 95篇 |
2012年 | 204篇 |
2011年 | 201篇 |
2010年 | 113篇 |
2009年 | 80篇 |
2008年 | 143篇 |
2007年 | 147篇 |
2006年 | 152篇 |
2005年 | 141篇 |
2004年 | 148篇 |
2003年 | 131篇 |
2002年 | 125篇 |
2001年 | 138篇 |
2000年 | 129篇 |
1999年 | 129篇 |
1998年 | 55篇 |
1997年 | 50篇 |
1996年 | 45篇 |
1995年 | 35篇 |
1994年 | 38篇 |
1993年 | 37篇 |
1992年 | 65篇 |
1991年 | 66篇 |
1990年 | 47篇 |
1989年 | 55篇 |
1988年 | 51篇 |
1987年 | 74篇 |
1986年 | 60篇 |
1985年 | 54篇 |
1984年 | 39篇 |
1983年 | 37篇 |
1982年 | 23篇 |
1981年 | 27篇 |
1980年 | 24篇 |
1979年 | 31篇 |
1978年 | 25篇 |
1976年 | 29篇 |
1974年 | 24篇 |
1973年 | 25篇 |
1971年 | 31篇 |
1970年 | 20篇 |
排序方式: 共有3788条查询结果,搜索用时 15 毫秒
71.
Yibai Li Kate A Jackson Barry Slon Janet R Hardy Michael Franco Leeroy William Peter Poon Janet K Coller Mark R Hutchinson David C Currow Andrew A Somogyi 《British journal of clinical pharmacology》2015,80(2):276-284
Aims
Ketamine analgesia is limited by low intrinsic efficacy compounded by large interindividual variability in drug responses, possibly due to the heterogeneity in drug concentration. The CYP2B6*6 allele is associated with substantially reduced ketamine metabolism in vitro and, therefore, may affect ketamine clearance. Our aims were to examine the impact of the CYP2B6*6 allele on ketamine plasma clearance and on adverse effects in chronic pain patients.Methods
CYP2B6 genotypes were identified in 49 chronic pain patients who received 24 h continuous subcutaneous infusions of ketamine. Steady-state plasma concentrations of ketamine (Css,k) and norketamine (Css,nk) were determined using HPLC.Results
The median plasma clearance of ketamine after 100 mg 24 h–1 dose was significantly lower in patients with the CYP2B6*6/*6 (21.6 l h–1) and CYP2B6*1/*6 (40.6 l h–1) genotypes compared with patients with the CYP2B6*1/*1 genotype (68.1 l h–1, P < 0.001). The ketamine : norketamine plasma metabolic ratio was significantly higher in patients with the CYP2B6*6/*6 genotype than in those with the CYP2B6*1/*6 and the CYP2B6*1/*1 genotypes (P < 0.001). Patients who experienced adverse effects had lower plasma clearance (45.6 l h-1) than those who did not (52.6 l h-1, P = 0.04). The CYP2B6*6 genotype and age, and their combined impact explained 40%, 30% and 60% of the variation in Css,k, respectively. Similar results were observed after higher doses.Conclusions
The CYP2B6*6 allele is associated with a substantial decrease in steady-state ketamine plasma clearance in chronic pain patients. The decreased clearance and resultant higher plasma concentrations may be associated with a higher incidence of ketamine adverse effects. 相似文献72.
Brand C Sundararajan V Jones C Hutchinson A Campbell D 《Internal medicine journal》2005,35(5):296-299
Comprehensive disease management programmes for chronic disease aim to improve patient outcomes and reduce health-care utilization. Readmission rates are often used as an outcome measure of effectiveness. This study aimed to document readmission rates, and risk for early and late readmission, for patients discharged from the Royal Melbourne Hospital with a disease diagnosis of chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD) or diabetes mellitus compared to those with other general medical conditions. Eighty five (8.6%) of patients were readmitted within 28 days and 183 (20.8%) were readmitted between 29 and 180 days. No risk factors for early readmission were identified. Patients with a primary disease diagnosis of CHF and COPD are at increased risk of late readmissions (29-180 days). 相似文献
73.
74.
Coakley G; Mok CC; Hajeer AH; Ollier WE; Turner D; Sinnott PJ; Hutchinson IV; Panayi GS; Lanchbury JS 《Rheumatology (Oxford, England)》1998,37(9):988-991
OBJECTIVE: To examine whether promoter polymorphisms associated with
variation in interleukin-10 (IL-10) production are relevant to the
development of rheumatoid arthritis (RA) or Felty's syndrome (FS). METHODS:
DNA was obtained from 44 FS patients, 117 RA patients and 295 controls. The
promoter region between -533 and - 1120 was amplified by polymerase chain
reaction, and polymorphisms detected by restriction enzyme digest or
sequence-specific oligonucleotide probing. RESULTS: We found no significant
difference in allele or haplotype frequencies between the groups.
CONCLUSION: There is no association between FS or RA and these recently
identified IL-10 promoter polymorphisms. Other genetic or environmental
factors could explain the alterations in IL-10 levels seen in these
conditions.
相似文献
75.
Hollenberg NK Anzalone DA Falkner B Fisher ND Hopkins PN Hsueh W Hutchinson H Krauss RM Price DA Raskin P Reaven GM 《American journal of hypertension》2001,14(3):218-223
BACKGROUND: Although it is widely recognized that there are familial elements in the pathogenesis of hypertension, remarkably little is known about the influence of family history on response to specific antihypertensive agents. METHODS: This study was designed to address that issue by comparing the depressor response to lisinopril in a dose range of 10 to 40 mg in 74 patients enrolled as sibling pairs. Because all patients were treated with lisinopril, ambulatory blood pressure monitoring (ABPM), an objective measure not influenced by the investigators, was used to assess the primary blood pressure (BP) outcome variable. RESULTS: Diastolic BP was highly correlated between sibling pairs at baseline (r = 0.476; P < .03) and on treatment (r = 0.524; P = .0021). Ethnicity/race had a striking influence on lisinopril dose and response rate. Among African American patients, 23 of 28 reached the top dose of 40 mg/day, whereas only 14 of 36 Caucasian patients reached that dose level. Among Caucasians, 92% responded, and only 48% of African Americans. Responders were characterized by being younger and heavier, having significantly lower microalbuminuria at baseline, higher baseline renal plasma flow (RPF), and higher urinary kallikrein. CONCLUSION: Among Caucasians, the presence of a hypertensive sibling predicts a striking therapeutic response to angiotensin converting enzyme inhibition. 相似文献
76.
J V Hunter M Chadwick G Hutchinson M E Hodson 《British journal of diseases of the chest》1985,79(1):1-8
Evidence of anaerobic infection was sought in 83 patients with pulmonary disease with anaerobic culture and gas liquid chromatography (GLC) of mucopurulent sputum, or pleural fluid where appropriate. Saliva samples from nine healthy controls and 14 patients with cystic fibrosis were examined by the same methods to assess anaerobic content. Clinically significant anaerobic pleuropulmonary infection was not found in our patients with bronchitis, bronchiectasis and cystic fibrosis and occurred in only some of our patients with empyema and lung abscess. GLC of pleural fluid (empyema) or sputum (lung abscess) was helpful in identifying these cases, when a strongly positive reading was obtained. The gas liquid chromatogram was negative or only weakly positive in those patients where the presence of anaerobes was clinically insignificant, most probably resulting from contamination of the sputum samples by saliva. Results were rapidly available and the need for transtracheal aspiration to obtain specimens of bronchial secretion uncontaminated by mouth flora was avoided. The semiquantitative GLC would therefore appear to be a useful method for investigating specimens from patients with suspected anaerobic pleuropulmonary infection. 相似文献
77.
78.
Mattey DL Hutchinson D Dawes PT Nixon NB Clarke S Fisher J Brownfield A Alldersea J Fryer AA Strange RC 《Arthritis and rheumatism》2002,46(3):640-646
OBJECTIVE: To determine whether the relationship between smoking and disease severity in women with rheumatoid arthritis (RA) is associated with polymorphism at the glutathione S-transferase (GST) M1 locus. METHODS: Genotyping for GSTM1 was carried out using polymerase chain reaction methodology on 164 women with established RA. Smoking history was obtained on each patient. Radiographic damage was measured by the Larsen score, and functional outcome was assessed by the Health Assessment Questionnaire (HAQ). Data were analyzed by multiple regression analyses, with correction for age and disease duration. RESULTS: Ever having smoked was associated with a worse radiographic and functional outcome than was never having smoked. Both past and current smoking were associated with increased disease severity. Stratification by GSTM1 status revealed that polymorphism at this locus affected the relationship between smoking and disease outcome measures. Patients who lacked the GSTM1 gene and had ever smoked had significantly higher Larsen and HAQ scores than did those who lacked the gene and had never smoked. Radiographic outcome in these patients was worse than that in patients who had the GSTM1 gene and who had smoked. The associations were not affected by correction for socioeconomic status. Rheumatoid factor (RF) production was found to be associated with smoking in only the GSTM1-null patients. CONCLUSION: Our data suggest that disease outcome in female RA patients with a history of smoking is significantly worse than in those who have never smoked. Smoking was associated with the most severe disease in patients who carried the GSTM1-null polymorphism. This association may be due in part to a relationship between the GSTM1 polymorphism and RF production in smokers. 相似文献
79.
Rapid identification of donor and recipient cells after allogeneic bone marrow transplantation using specific genetic markers 总被引:3,自引:0,他引:3
R. M. Hutchinson J. H. Pringle L. Potter I. Patel † A. J. Jeffreys † 《British journal of haematology》1989,72(2):133-140
The fate of the donor graft in allogeneic bone marrow transplantation, the presence of chimaerism and early relapse can be monitored by identification of the donor or recipient origin of haemopoietic cells in peripheral blood and bone marrow. We have done this by the use of highly informative locus-specific hypervariable DNA probes in two sex and blood group matched transplants. In four sex mismatched transplants the Y chromosome was identified by in situ hybridization using a biotinylated Y probe. Early engraftment by day 13 was detected in five of the six patients. Transient chimaerism occurred in half of the cases and was accompanied by the temporary appearance of the Philadelphia chromosome in one patient with chronic myeloid leukaemia without subsequent relapse. Persistence of the graft in the face of falling peripheral counts was documented in four of the six patients studied. The morphology as well as origin of the haemopoietic cells could be characterized by the Y probe analysis. In one patient, recipient lymphocytes were shown to co-exist with myeloid series of donor origin. We conclude that both techniques are highly specific, sensitive and can provide information within 24-48 h. Thus they are of value in guiding early therapeutic intervention in allogeneic transplantation. 相似文献
80.